Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06065436 · ClinicalTrials.gov registry record · NA
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
A NA study of Erectile Dysfunction and Peyronie Disease, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06065436: Recruiting NA study of Erectile Dysfunction and Peyronie Disease, sponsored by Mayo Clinic.
NCT06065436 is a NA study of Erectile Dysfunction and Peyronie Disease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06065436, a NA study of Erectile Dysfunction and Peyronie Disease, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to determine whether or not low-intensity shockwave therapy (LiSWT) with Xiaflex treatment will result in greater improvements to the curvature of the penis.
Primary Outcome
Measured using the validated Peyronie's Disease Questionnaire (PDQ) subdomain symptom bother. Four questions to evaluate pain or discomfort during vaginal intercourse: responses include "not at all bothered", "a little bit bothered" , "moderately bothered", "very bothered", "extremely bothered"
Conditions Studied
Interventions
- DRUG Collagenase Clostridium Histolyticum
- DEVICE Storz Duolith LiSWT
Study Locations (1)
Minnesota
- Mayo Clinic Minnesota - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-01-19 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT06065436 shows while recruiting
NCT06065436 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 230-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Erectile Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Collagenase Clostridium Histolyticum is the first listed.
NCT06065436 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06065436 about?
NCT06065436 is a clinical study titled "Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease". The purpose of this research is to determine whether or not low-intensity shockwave therapy (LiSWT) with Xiaflex treatment will result in greater improvements to the curvature of the penis.
What is the current status of trial NCT06065436?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-01-19. Estimated completion is 2027-01.
What conditions does trial NCT06065436 study?
This clinical trial studies the following conditions: Erectile Dysfunction, Peyronie Disease.
What interventions are being tested in trial NCT06065436?
The interventions under investigation include: Collagenase Clostridium Histolyticum (DRUG), Storz Duolith LiSWT (DEVICE).
Who is sponsoring clinical trial NCT06065436?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06065436 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06065436's enrollment target sits among peer trials
60 18th of 33 higher than 16 of 33 other Erectile Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Erectile Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Double-S: a Wearable Device for Erectile Dysfunction
RECRUITING · NA
-
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
RECRUITING · NA
-
The Impact of Dietary Pattern on Erectile Function
RECRUITING · NA
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
-
The Impact of a Plant-based Meat Meal Versus an Animal Meat Meal on Erectile Function in Healthy Men.
RECRUITING · NA
-
Penile Lengthening Pre-Penile Prosthesis Implantation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI